儿童CKD中ACEI早期降蛋白尿可预测肾脏生存
该研究分析ESCAPE试验中280例2-4期CKD患儿,均接受固定剂量雷米普利并随机分组血压控制目标。
要点
- 儿童CKD用ACEI后早期蛋白尿降幅越大,长期肾脏生存越好
- 蛋白尿降幅>60%者肾脏终点风险显著低于<30%者
- 降蛋白尿应作为儿童CKD管理的重要目标
核心结论
- ACEI早期降蛋白尿作用与儿童CKD长期肾功能保护相关。
研究设计与样本
- ESCAPE试验中280例2-4期CKD患儿,平均年龄11.7岁,中位eGFR 46 ml/min per 1.73 m2,71%为先天性肾畸形,接受雷米普利6 mg/m2每日并随机分组血压控制。
主要发现
- 雷米普利平均降低蛋白尿43.5%(95%CI 36.3%至49.9%)。
- 相对蛋白尿降幅<30%,降幅30%-60%和>60%的肾脏终点风险比分别为0.70(95%CI 0.40至1.22)和0.42(95%CI 0.22至0.79)。
- 5年观察期内80例达到肾脏终点(eGFR下降50%或ESRD)。
- 关联独立于年龄、性别、CKD诊断、基线eGFR、基线蛋白尿、初始血压及伴随血压下降。
临床怎么用
- 儿童CKD启用ACEI后应早期评估蛋白尿降幅,降幅不足提示肾脏保护可能不充分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Although pharmacotherapeutic proteinuria lowering was found to be nephroprotective in adults, the predictive value of early drug-induced proteinuria reduction for long-term renal survival in pediatric CKD is unknown. We analyzed data from the ESCAPE Trial for a potential association between initial antiproteinuric effect of standardized angiotensin-converting enzyme (ACE) inhibition and renal disease progression in children with CKD.Methods In total, 280 eligible children with CKD stages 2-4 (mean age 11.7 years old, median eGFR 46 ml/min per 1.73 m2, 71% congenital renal malformations) received a fixed dose of ramipril (6 mg/m2 per day) and were subsequently randomized to conventional or intensified BP control. We assessed initial proteinuria reduction from baseline to first measurement on ramipril (at 2.5±1.3 months). We used multivariable Cox modeling to estimate the association between initial proteinuria reduction and the risk of reaching a renal end point (50% eGFR decline or ESRD), which occurred in 80 patients during 5 years of observation.Results Ramipril therapy lowered proteinuria by a mean of 43.5% (95% confidence interval, 36.3% to 49.9%). Relative to proteinuria reduction <30%, 30%-60% and >60% reduction resulted in hazard ratios (95% confidence intervals) of 0.70 (0.40 to 1.22) and 0.42 (0.22 to 0.79), respectively. This association was independent of age, sex, CKD diagnosis, baseline eGFR, baseline proteinuria, initial BP, and concomitant BP reduction.Conclusions The early antiproteinuric effect of ACE inhibition is associated with long-term preservation of renal function in children with CKD. Proteinuria lowering should be considered an important target in the management of pediatric CKD.
引用
- van den Belt SM, Heerspink HJL, Gracchi V, et al. Early Proteinuria Lowering by Angiotensin-Converting Enzyme Inhibition Predicts Renal Survival in Children with CKD. J Am Soc Nephrol. 2018. PMID: 29930161. doi:10.1681/ASN.2018010036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。